|
2022
|
Invention
|
Modified producer cells for extracellular vesicle production. The present disclosure provides met... |
|
|
Invention
|
Extracellular vesicle comprising cholesterol tagged sting-agonist. Provided herein are EVs, e.g.,... |
|
|
Invention
|
Extracellular vesicle compositions. e.ge.g., exosomes) that can comprise an antisense oligonucleo... |
|
|
Invention
|
Methods of loading extracellular vesicles. The present disclosure relates to methods of loading a... |
|
|
Invention
|
Extracellular vesicle-nlrp3 antagonist. The present disclosure relates to extracellular vesicles,... |
|
|
Invention
|
Extracellular vesicle linked to a biologically active molecule via an optimized linker and an anc... |
|
2021
|
Invention
|
Extracellular vesicle-aso constructs targeting stat6. e.gSTAT6STAT6 transcript. Also provided her... |
|
|
Invention
|
Extracellular vesicles comprising kras antigens and uses thereof. The present disclosure relates ... |
|
|
Invention
|
Methods of producing extracellular vesicles. The present disclosure relates to extracellular vesi... |
|
|
Invention
|
Process for preparing extracellular vesicles. The present disclosure relates to methods for prepa... |
|
|
Invention
|
Process for preparing extracellular vesicles. The present disclosure relates to multistep chromat... |
|
|
Invention
|
Methods of treating cancer. The present disclosure relates to methods of treating a cancer in a s... |
|
|
Invention
|
Anti-transferrin extracellular vesicles. e.g.e.g.e.g.e.g., a vNAR, a VHH, or a fragment thereof, ... |
|
|
Invention
|
Methods of targeting extracellular vesicles to lung. The present disclosure relates to methods to... |
|
|
Invention
|
Extracellular vesicles for therapy. e.g.e.g., infectious diseases. |
|
|
Invention
|
Extracellular vesicle-aso constructs targeting pmp22. e.g.PMP22PMP22) transcript. Also provided h... |
|
|
Invention
|
Targeted delivery of extracellular vesicles. e.g.e.ge.g., exosome, comprises a biologically activ... |
|
|
Invention
|
Extracellular vesicles for treating neurological disorders. e.ge.g., neurological disorders). |
|
|
Invention
|
Methods of treating neuroinflammation. e.ge.g., exosomes, comprising an M2 polarization agent. In... |
|
|
Invention
|
Cholesterol assays for quantifying extracellular vesicles. Provided herein are methods of quantif... |
|
2020
|
Invention
|
High-throughput chromatography screening for extracellular vesicles. e.ge.ge.ge.g., improving EV ... |
|
|
Invention
|
Methods of producing extracellular vesicles. e.g e.g e.g., exosomes, with various cyclic dinucleo... |
|
|
Invention
|
Extracellular vesicle compositions. e.g.e.g.e.g., 1, 2, 3, 4, 5 or more) exogenous biologically a... |
|
|
Invention
|
Exogenous loading of exosomes via lyophilization. e.ge.g., exosomes) with exogenous cargo, compos... |
|
|
Invention
|
Sting agonist comprising exosomes for treating neuroimmunological disorders. e.ge.ge.g., EVs comp... |
|
|
Invention
|
Sting agonist comprising exosomes combined with il-12 displaying exosomes for treating a tumour. ... |
|
|
Invention
|
Extracellular vesicles with stat3-antisense oligonucleotides. The present disclosure relates to m... |
|
|
Invention
|
Extracellular vesicles with nras antisense oligonucleotides. The present disclosure relates to mo... |
|
|
Invention
|
Extracellular vesicle-nlrp3 antagonist. e.g.e.g., exosomes, comprising an NLRP3 antagonist. In so... |
|
|
Invention
|
Extracellular vesicle-aso constructs targeting cebp/beta. The present disclosure relates to extra... |
|
|
Invention
|
Extracellular vesicles with antisense oligonucleotides targeting kras. The present disclosure rel... |
|
|
Invention
|
Extracellular vesicle-aso constructs targeting stat6. The present disclosure relates to extracell... |
|
|
Invention
|
Extracellular vesicle linked to molecules and uses thereof. The present disclosure relates to ext... |
|
|
Invention
|
Methods of inducing hematopoiesis. e.g.e.g., exosomes, comprising a FLT3L polypeptide. Also provi... |
|
|
Invention
|
Extracellular vesicles targeting t cells and uses thereof. e.ge.ge.ge.g., T cells). Also provided... |
|
|
Invention
|
Compositions of exosomes and aav. The present disclosure relates to extracellular vesicles, e.g.,... |
|
|
Invention
|
Methods of treating tuberculosis. e.ge.gMycobacterium tuberculosise.ge.g., IL-12, and, optionally... |
|
|
Invention
|
Extracellular vesicles for vaccine delivery. The present disclosure relates to extracellular vesi... |
|
|
Invention
|
Extracellular vesicle conjugates and uses thereof. The present disclosure relates to extracellula... |
|
|
Invention
|
Treatment of cancer metastasis by targeting exosome proteins. The present disclosure provides a t... |
|
|
Invention
|
Membrane protein scaffolds for exosome engineering. The present disclosure relates to heterologou... |
|
2019
|
Invention
|
Methods to improve potency of electroporation. Compositions and methods for reducing nucleotide o... |
|
|
Invention
|
Extracellular vesicles targeting dendritic cells and uses thereof. e.g.e.g.e.g., dendritic cells)... |
|
|
Invention
|
Methods of measuring extracellular vesicles and nanoparticles in complex matrices by light scatte... |
|
|
Invention
|
Engineered extracellular vesicles and uses thereof. The present disclosure relates to therapeutic... |
|
|
Invention
|
Extracellular vesicles comprising sting-agonist. Provided herein are compositions comprising EV, ... |
|
|
Invention
|
Methods and compositions for macrophage polarization. Disclosed herein are compositions and metho... |
|
2018
|
Invention
|
Exosomes for immuno-oncology and anti-inflammatory therapy. Disclosed herein are extracellular ve... |
|
2017
|
Invention
|
Therapeutic membrane vesicles.
The present invention relates to a method for producing membrane ... |
